Early diagnosis of ALS/MND.
With the advent of a specific biological therapy for ALS there is an increasing imperative for early diagnosis. As new, more effective therapies become available, this will become more important. It is intuitively probable that early therapy will prevent disability in this otherwise relentlessly progressive disorder. The difficulties posed by this need for early diagnosis in clinical practice are discussed.
Swash
M
M
Department of Neurology, St Bartholomew's and The Royal London School of Medicine and Dentistry, The Royal London Hospital, UK. M.Swash@mds.qmw.ac.uk
D000690:Amyotrophic Lateral Sclerosis / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics; D003937:Diagnosis, Differential; D004576:Electromyography; D006801:Humans; D008875:Middle Aged; D011379:Prognosis; D019782:Riluzole / Q000627:therapeutic use; D013482:Superoxide Dismutase / Q000235:genetics; D013997:Time Factors
D019782:Riluzole; D013482:Superoxide Dismutase